Skip to search formSkip to main contentSkip to account menu

rabeximod

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

IndolesQuinoxalines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Anti‐inflammatory treatment of traumatic brain injury with Rabeximod reduces cerebral antigen presentation in mice
A major component of the damaging effect after traumatic brain injury (TBI) is activation of the inflammatory system. In… 
2011
2011
The novel anti-rheumatic compound Rabeximod impairs differentiation and function of human pro-inflammatory dendritic cells and macrophages.
2010
2010
Rabeximod reduces arthritis severity in mice by decreasing activation of inflammatory cells
Objectives The novel small molecule 9-chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxaline… 
2008
2008
The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders
Objectives: Autoimmune diseases such as rheumatoid arthritis (RA) and multiple sclerosis (MS) affect a relatively large portion… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)